The AI infrastructure trade is printing real money: SK Hynix’s Nasdaq debut raised $26.5 billion on Day One, Micron locked in $22 billion in customer commitments, and memory is no longer a sleepy semiconductor footnote.
The through-line this morning is the distance between headline hype and actual execution, a gap showing up in AstraZeneca’s pipeline stumble, Salesforce’s Agentforce skepticism, and the grocery aisle where value is winning and volume is not.
1. The Lead · Semiconductors
SK Hynix (SKHY) rose 13% on its first day of trading on Nasdaq, closing at $168.01 against an ADR pricing of $149, and raised $26.5 billion for factory expansion, according to CNBC. Chairman Chey Tae-won told CNBC’s Kristina Partsinevelos that customers who heard SK Hynix would double capacity in five years responded: “That’s not enough, man.” The company’s valuation has risen more than sevenfold over the past year, driven by its dominance in high-bandwidth memory (HBM), the stacked chip architecture that powers Nvidia’s AI accelerators. SK Hynix has committed to a $390 billion chip fabrication cluster in Yongin, South Korea, plus a $4 billion advanced packaging plant in Indiana. The listing comes roughly a month after SpaceX’s record IPO, underscoring that the largest capital formation events of 2026 are happening in AI infrastructure, not consumer software.
$390B: Planned cost of SK Hynix’s chip fabrication cluster in Yongin, South Korea, per CNBC.
The Bull & The Bear
▲ Bull: HBM demand is structurally different from prior memory cycles. AI training and inference workloads require far more bandwidth-intensive memory than smartphones or PCs ever did, and SK Hynix is the technology leader in HBM supply to Nvidia, the world’s most valuable company. The $26.5 billion raised gives it a real runway to expand capacity before competitors can close the gap.
▼ Bear: Memory is cyclical, full stop. Every prior technology wave, from dot-com to smartphones to cloud, eventually produced oversupply and a price collapse. The current shortage is driven by a narrow set of hyperscaler customers. If AI capex budgets cool, get renegotiated, or if a cheaper memory architecture emerges, SK Hynix’s sevenfold valuation run becomes a liability, not a moat.
The Bull Street Take
I think the market is right to pay up here, with one caveat. The HBM shortage is real and the customers are real. When Nvidia’s supply chain says it needs more chips after you just announced a capacity doubling, that is a demand signal worth taking seriously. The cyclicality risk is also real, but the AI infrastructure buildout has years of runway left. SK Hynix’s Nasdaq listing is not just a capital event. It is the formal elevation of memory into the same conversation as logic chips and GPUs.
Markets in Review · The Tape
Markets in Review
All three major indexes closed higher on Friday, July 10 to cap a choppy week. The S&P 500 rose 0.42% to 7,575.39, the Nasdaq Composite added 0.29% to 26,281.61, and the Dow gained 149.61 points, or 0.29%, to 52,637.01, with SK Hynix’s blockbuster Nasdaq debut anchoring the session.
Friday’s tape was carried by megacap tech. Nvidia (NVDA) rose roughly 4% and Meta Platforms (META) jumped about 6%, together doing most of the index’s heavy lifting even as breadth stayed narrow. The centerpiece was SK Hynix’s (SKHY) Nasdaq listing, which opened at $170 for a pop of more than 14% over its $149 ADR pricing before closing at $168.01, up 13% on the day. Investors also tracked U.S.-Iran ceasefire talks, which stayed fluid into the close.
Risk appetite firmed into the weekend. The VIX fell 5.1% to 15.03, while the 10-year Treasury yield finished near 4.56% as Middle East headlines kept a bid in rates. In commodities, WTI crude slipped about 0.9% to near $71 a barrel and gold eased 0.65% to $4,113.70. Delta Air Lines (DAL) was a notable laggard, falling after flagging substantial fuel costs despite an earnings beat.
On the downside, AstraZeneca (AZN) extended its slide, shedding roughly 3% on Friday after Thursday’s 6.2% drop, its worst single session in over two years, on the Wainua trial failure. Salesforce (CRM) stayed under pressure after the week’s dual KeyBanc and Bernstein downgrades to Sector Weight.
Go deeper
S&P 500 closed at 7,575.39 (+0.42%), the Nasdaq at 26,281.61 (+0.29%), and the Dow at 52,637.01 (+0.29%), all three finishing green to end the week.
SK Hynix (SKHY) opened at $170, a 14%-plus pop over its $149 ADR pricing, and closed at $168.01, up 13%, as Nvidia (+4%) and Meta (+6%) led the megacap complex.
Rates and vol cooled: the 10-year yield sat near 4.56% and the VIX fell 5.1% to 15.03, while WTI crude held near $71 (-0.9%) and gold settled at $4,113.70 (-0.65%).
What they’re saying
“AstraZeneca has bold plans to hit $80 billion in sales by 2030, and investors will now be asking if this target is credible.” -- Dan Coatsworth, Head of Markets, AJ Bell
2. Pharma · Biotech
AstraZeneca (AZN) shares fell 6.2% in a single session after its Wainua drug failed a late-stage trial for ATTR cardiomyopathy, then dropped an additional 3% the next day, according to CNBC. Most analysts, including Citi, Jefferies, and Leerink Partners, pegged the net present value impact at just 2-4%, making the roughly double market reaction a vote against AstraZeneca’s broader pipeline premium rather than the drug itself. Jefferies called Wainua “a slam dunk” that wasn’t, and noted the failure narrows the headroom above management’s 2030 $80 billion revenue target to roughly $80.8 billion. All three firms, along with Bank of America, still recommend buying the stock, with Citi reiterating AstraZeneca as its top European pharmaceutical pick. Next catalyst to watch: the AVANZAR lung cancer trial, expected to report in July or August.
$80B: AstraZeneca’s 2030 revenue target, now under greater scrutiny after the Wainua trial miss, per CNBC.
3. Earnings · Banks
Five major U.S. banks are set to report earnings on the same day this week, and according to MarketWatch, Citigroup (C) is expected to show the greatest improvement by at least one key performance measure among the group. The catch: Citi still has a significant gap to close before hitting its own internal performance targets. With bank earnings functioning as a read on credit quality, net interest margin trends, and trading desk activity, the Citi print will carry outsized interpretive weight for the entire sector.
4. Tech · AI Software
KeyBanc Capital Markets and Bernstein both downgraded Salesforce (CRM) to Sector Weight on the same day, a rare dual downgrade, after concluding that adoption of Agentforce, its flagship AI agent platform, is progressing more slowly than headline numbers suggest, according to Yahoo Finance. KeyBanc analyst Jackson Ader was blunt, telling clients the only real reason to own the stock now is valuation. The deeper structural concern is that if AI agents replace human users, customers may need fewer per-seat licenses, potentially shrinking Salesforce’s core revenue stream rather than growing it. Salesforce is piloting a usage-based pricing model for agents, but that model remains unproven at scale.
5. Deals · Renewables
GoldenPeaks Poland Holding filed Chapter 11 in the Southern District of Texas on May 29, 2026, with $952 million in funded debt and fewer than €1.1 million in unencumbered cash, according to Yahoo Finance. The proximate cause was the collapse of Spectris Energy, a wholly owned subsidiary that ran every operational function across GoldenPeaks’ entire Polish solar portfolio. When Polish tax authorities froze Spectris’s accounts and suppliers walked, GoldenPeaks had no employees of its own to step in. Brookfield Asset Management, the controlling shareholder and most junior prepetition lender, is now the stalking horse bidder with a $162.8 million DIP loan. The 664 megawatts of operational capacity and all existing power purchase agreements with Nestle, Cargill, and others remain intact.
$952M: GoldenPeaks Poland’s total funded debt at time of Chapter 11 filing, against less than €1.1 million in cash, per Yahoo Finance.
★ Featured Event · Live Webinar
Oren Klaff shares his work with 400+ current investors, and on Thursday, July 30 at 9:00 AM PST he is doing it live: a real deal breakdown, plus the framework he uses to spot a private company with genuine upside before the broader market notices. 55 minutes, live only, no recording, and seats are limited. If you want to sharpen how you think about private-market access, be in the room.
+ Also on the Tape
From All Upside: Optimism is a discipline, not a mood
A record tape, a cracked jobs report, and the position Evelio is staking his name on. Why the factories and infrastructure going up right now make disciplined optimism the only rational read, and how to find the buildout nearest you.
AI / IPO: OpenAI co-founder Greg Brockman consolidates control over ChatGPT, enterprise, and compute after Fidji Simo stepped down due to chronic illness, putting more pressure on him to justify the company’s $852 billion valuation ahead of a prospective IPO.
Memory: Micron Technology (MU) disclosed $22 billion in strategic customer commitments across 16 agreements, including take-or-pay provisions and pricing floors, as management said AI demand could keep supply tight beyond 2027.
Consumer: Costco and Walmart are capturing grocery market share as 71% of American shoppers say inflation is a very or extremely serious concern, per the FMI’s June Grocery Shopper Snapshot.
Macro: U.S. grocery unit volume declined even as dollar sales grew 1.2% in 2025, with 2.2% price increases driving all of the gain, according to McKinsey’s State of Grocery North America 2026.
The Last Word
Capital flows to where the constraint is. Right now, the constraint is memory, not models.
Bull Street is for informational purposes only. Nothing here is financial advice. Always do your own research.
Comments
Nothing yet. Say the first thing.
Sign in to join the conversation.